HK1024622A1 - Il 12 for the gene therapy of tumours - Google Patents

Il 12 for the gene therapy of tumours

Info

Publication number
HK1024622A1
HK1024622A1 HK00103480A HK00103480A HK1024622A1 HK 1024622 A1 HK1024622 A1 HK 1024622A1 HK 00103480 A HK00103480 A HK 00103480A HK 00103480 A HK00103480 A HK 00103480A HK 1024622 A1 HK1024622 A1 HK 1024622A1
Authority
HK
Hong Kong
Prior art keywords
tumours
gene therapy
therapy
gene
Prior art date
Application number
HK00103480A
Other languages
English (en)
Inventor
Alexander L Rakhmilevich
Ning-Sun Yang
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of HK1024622A1 publication Critical patent/HK1024622A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00103480A 1996-06-05 2000-06-09 Il 12 for the gene therapy of tumours HK1024622A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/659,206 US5922685A (en) 1996-06-05 1996-06-05 IL-12 gene therapy of tumors
PCT/US1997/009591 WO1997046263A1 (en) 1996-06-05 1997-06-04 Il-12 gene therapy of tumors

Publications (1)

Publication Number Publication Date
HK1024622A1 true HK1024622A1 (en) 2000-10-20

Family

ID=24644498

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103480A HK1024622A1 (en) 1996-06-05 2000-06-09 Il 12 for the gene therapy of tumours

Country Status (7)

Country Link
US (1) US5922685A (xx)
EP (1) EP0963207B1 (xx)
JP (1) JP2000512980A (xx)
DE (1) DE69735643T2 (xx)
ES (1) ES2262180T3 (xx)
HK (1) HK1024622A1 (xx)
WO (1) WO1997046263A1 (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998041229A1 (en) * 1997-03-19 1998-09-24 F. Hoffmann-La Roche Ag USE OF IL-12p40 AS IMMUNOSTIMULANT
ES2221717T3 (es) 1997-12-08 2005-01-01 Emd Lexigen Research Center Corp. Proteinas de fusion heterodimeras utiles para inmunoterapia dirigida e inmunoestimulacion general.
US20030105294A1 (en) * 1998-02-25 2003-06-05 Stephen Gillies Enhancing the circulating half life of antibody-based fusion proteins
ATE329622T1 (de) * 1998-04-15 2006-07-15 Lexigen Pharm Corp Steigerung der antikörper-zytokin- fusionsproteinmediierten immunantwort durch mitverabreichung mit einem angiogeneseinhibitor
EP1030680A4 (en) * 1998-09-15 2003-05-02 Genetics Inst TREATMENT OF CAPOSISARCOMA WITH IL-12
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
US7067110B1 (en) 1999-07-21 2006-06-27 Emd Lexigen Research Center Corp. Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
AU778611B2 (en) * 1999-08-09 2004-12-16 Merck Patent Gmbh Multiple cytokine-antibody complexes
US20030190305A1 (en) * 1999-09-15 2003-10-09 Wyeth And National Institutes Of Health Treatment of Kaposi's sarcoma with IL-12
US6626871B1 (en) 1999-10-11 2003-09-30 Felton International, Inc. Method and apparatus for removing cap from medical device
US7074210B2 (en) * 1999-10-11 2006-07-11 Felton International, Inc. Universal protector cap with auto-disable features for needle-free injectors
KR20010108053A (ko) * 1999-10-29 2001-12-07 무라야마 마사노리 당뇨병성 허혈성 질환 유전자 치료
JP2003514552A (ja) 1999-11-12 2003-04-22 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 改善された性質を有するエリトロポエチンの形態
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7115712B1 (en) 1999-12-02 2006-10-03 Maxygen, Inc. Cytokine polypeptides
ATE336514T1 (de) * 2000-02-11 2006-09-15 Merck Patent Gmbh Steigerung der zirkulierenden halbwertzeit von auf antikörpern basierenden fusionsproteinen
US20040213798A1 (en) * 2000-06-08 2004-10-28 Powderject Vaccines, Inc. Spray-dried alum compositions
US20020120228A1 (en) * 2000-06-08 2002-08-29 Yuh-Fun Maa Powder compositions
JP5390055B2 (ja) * 2000-06-29 2014-01-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 免疫サイトカインの取り込み増強剤との併用治療による抗体−サイトカイン融合タンパク質媒介免疫応答の増強
US7255865B2 (en) * 2000-12-05 2007-08-14 Allergan, Inc. Methods of administering botulinum toxin
US20020086036A1 (en) 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
ES2393733T3 (es) * 2001-03-07 2012-12-27 Merck Patent Gmbh Tecnología de expresión para proteínas que contienen una fracción de anticuerpo de isotipo híbrido
WO2002079415A2 (en) 2001-03-30 2002-10-10 Lexigen Pharmaceuticals Corp. Reducing the immunogenicity of fusion proteins
RU2306320C9 (ru) * 2001-05-03 2008-01-27 Мерк Патент Гмбх Рекомбинантное опухолеспецифичное антитело (варианты) и его применение
CA2349506C (en) * 2001-06-14 2009-12-08 Duke University A method for selective expression of therapeutic genes by hyperthermia
CN100390282C (zh) * 2001-12-04 2008-05-28 默克专利有限公司 具有调节的选择性的il-2融合蛋白
US7169904B2 (en) * 2002-12-17 2007-01-30 Emd Lexigen Research Center Corp. Immunocytokine sequences and uses thereof
EP1702069A2 (en) * 2004-01-05 2006-09-20 EMD Lexigen Research Center Corp. Interleukin-12 targeted to oncofoetal fibronectin
JP5175214B2 (ja) 2005-12-30 2013-04-03 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 改良された安定性を有するインターロイキン−１２ｐ４０変種
US7833754B2 (en) * 2006-01-13 2010-11-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services IL-12 for expression in mammalian cell
ES2531522T3 (es) * 2007-10-08 2015-03-16 Intrexon Corporation Células dendríticas modificadas por ingeniería y usos para el tratamiento del cáncer
WO2010042189A2 (en) 2008-10-08 2010-04-15 Intrexon Corporation Engineered cells expressing multiple immunomodulators and uses thereof
US8556882B2 (en) 2009-04-30 2013-10-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inducible interleukin-12
WO2010147971A2 (en) * 2009-06-15 2010-12-23 New York University Il23 modified viral vector for recombinant vaccines and tumor treatment
RS63912B1 (sr) 2016-05-18 2023-02-28 Modernatx Inc Polinukleotidi koji kodiraju interleukin-12 (il12) i njihove upotrebe
EP3625246A1 (en) 2017-05-18 2020-03-25 ModernaTX, Inc. Polynucleotides encoding tethered interleukin-12 (il12) polypeptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5015580A (en) * 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
CA2501743C (en) * 1994-01-21 2008-11-18 Powderject Vaccines, Inc. Gas driven gene delivery instrument
JP2001503258A (ja) * 1996-10-18 2001-03-13 バレンティス・インコーポレーテッド 遺伝子発現および搬送系および用途

Also Published As

Publication number Publication date
EP0963207A4 (en) 2003-01-22
WO1997046263A1 (en) 1997-12-11
ES2262180T3 (es) 2006-11-16
EP0963207A1 (en) 1999-12-15
US5922685A (en) 1999-07-13
JP2000512980A (ja) 2000-10-03
DE69735643D1 (de) 2006-05-18
DE69735643T2 (de) 2006-12-14
EP0963207B1 (en) 2006-04-05

Similar Documents

Publication Publication Date Title
HK1024622A1 (en) Il 12 for the gene therapy of tumours
GB9622500D0 (en) Therapeutic gene
AU3972893A (en) Gene therapy using the intestine
ZA961587B (en) Gene transfer-mediated angiogenesis therapy
IL117309A0 (en) Gene transfer-mediated angiogenesis therapy
GB9421709D0 (en) Therapeutic compounds
HK1003711A1 (en) Therapeutic compounds
EP0723460A4 (en) GENE THERAPY FOR THE NERVOUS SYSTEM
AU2508597A (en) Drug for the treatment of tumours
ZA9533B (en) Pentolifylline therapy
GB9700939D0 (en) Therapy
ZA959846B (en) Enzyme prodrug therapy
GB9703633D0 (en) Cancer therapy
EP0727486A3 (en) Gene that suppresses tumors
ZA984650B (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
GB9310441D0 (en) Gene therapy
ZA951482B (en) Therapeutic benzonitriles
GB9418696D0 (en) Gene therapy
GB9403408D0 (en) Therapeutic benzonitriles
GB2333527B (en) Therapeutic gene
GB9520433D0 (en) Gene therapy
GB9521711D0 (en) Gene therapy
GB9423368D0 (en) Gene therapy constructs
GB9626969D0 (en) Conjugate compounds useful for non-viral gene therapy and methods for the production thereof
GB9727456D0 (en) Conjugate compounds useful for non-viral gene therapy and methods for the production thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100604